Infimab, the brand name for Infliximab 100mg Injection, is a medication used to treat various autoimmune disorders such as rheumatoid arthritis, Crohn’s disease, ulcerative colitis, and psoriasis. The drug is manufactured by Ranbaxy Laboratories Ltd. and is available in a pack of one vial.
The active ingredient in Infimab is Infliximab, which is a monoclonal antibody that works by blocking the action of tumor necrosis factor (TNF) alpha, a substance in the body that causes inflammation. By doing this, Infimab helps to reduce inflammation and improve the symptoms of autoimmune disorders.
Infimab is administered intravenously (IV) by a healthcare professional in a clinical setting. The dosage and treatment duration may vary depending on the condition being treated and the patient’s response to the medication. Injection may be given every 4-8 weeks based on the condition and severity of the disease.
The medication comes in a pack of one vial with a strength of 100mg. The drug should only be administered by a healthcare professional and is not available without a prescription. It is important to inform your healthcare provider about any allergies or other medical conditions you have before starting treatment with Infimab.
Some side effects of Infimab may include headache, fever, chills, nausea, vomiting, and skin rash. Rare but serious side effects may include heart failure or worsening of heart failure, infections, and certain types of cancer. It is important to discuss any concerns you may have with your healthcare provider.
In summary, Infimab or Infliximab 100mg Injection is a monoclonal antibody used to treat autoimmune disorders by blocking the action of TNF alpha. It is administered intravenously by a healthcare professional in a clinical setting and is available only with a prescription. The drug is manufactured by Ranbaxy Laboratories Ltd. and comes in a pack of one vial.